MedTrace Logo

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

NCT05783544 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-08-01

No results posted yet for this study

Summary

The prevalence of ascariasis in COPD patients with and without concomitant pulmonary aspergillosis and in controls will be determined. To assess the influence of ascaridosis on the development of pulmonary aspergillosis in COPD patients cytokine status of patients will be studied.

Conditions

  • COPD Exacerbation Acute
  • Ascaris Lumbricoides Infection
  • Chronic Pulmonary Aspergillosis

Interventions

DIAGNOSTIC_TEST

Interleukin-1B

Level of serum interleukin-1B will be detected

DIAGNOSTIC_TEST

Interleukin-4

Level of serum interleukin-4 will be detected

DIAGNOSTIC_TEST

Interleukin-6

Level of serum interleukin-4 will be detected

DIAGNOSTIC_TEST

tumor necrosis factor - a

Level of serum tumor necrosis factor - a will be detected

DIAGNOSTIC_TEST

interferon- gamma

Level of serum interferon- gamma will be detected

Sponsors & Collaborators

  • Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Uzbekistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05783544 on ClinicalTrials.gov